New Horizons in Medicine and Medical Research Vol. 10

  • Home
  • About
  • Books
  • Testimonials
  • Editors
  • Charges
  • Submission
  • Contact
Advanced Search
  1. Home
  2. Books
  3. New Horizons in Medicine and Medical Research Vol. 10
  4. Chapters


Single-cell Whole RNA Sequencing from Tumor-Infiltrating Lymphocyte

  • Biaoru Li
  • Yunbo Xu

New Horizons in Medicine and Medical Research Vol. 10, 19 May 2022 , Page 167-173
https://doi.org/10.9734/bpi/nhmmr/v10/6129F Published: 2022-05-19

  • View Article
  • Cite
  • Share

Abstract

 

The study highlights a genomic approach combining single-cell mRNA differential display and RNA subtractive hybridization to elucidate the CD8 T-cell silence ten years ago. To study the feasibility of the whole RNA sequencing technique (RNA-seq) for gene expression at a single-cell level, here, we used one similar RNA specimen from the amplified RNA to run RNA high-throughput transcriptome sequencing (RNA-Seq). We found that results of RNA-seq were higher related to those of single-cell mRNA differential display and single-cell qPCR. The pair correlation of gene expression levels from normalized RPKM (reads per kilobase of transcript per million mapped reads) was 0.58-0.81 to those from qrtPCR among genes, which were uncovered for up-regulated genes (Tob, TGF- \(\beta\) , LKLF, SnoA, Ski, Myc, ERF and REST/NRSF complex) in the T-cell silent status. The results demonstrate the feasibility of using RNA-Seq to study the transcriptome at the single-cell level.

 

Keywords:
  • Single-cell genomics analysis
  • RNA-seq
  • quiescent status
  • CD8
  • T-cell
  • tumor-infiltrating lymphocytes (TILs)

How to Cite

Li, B., & Xu , Y. (2022). Single-cell Whole RNA Sequencing from Tumor-Infiltrating Lymphocyte. New Horizons in Medicine and Medical Research Vol. 10, 167–173. https://doi.org/10.9734/bpi/nhmmr/v10/6129F
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX
  • Linkedin
  • Twitter
  • Facebook
  • WhatsApp
  • Telegram

© B P International